Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-18

FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for mesalamine by Zydus Lifesciences Limited, updating or expanding its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)